In order to present a proof-of-principle application of the molBLOCKS suite, we performed fragmentation and enrichment analysis on antineoplastic drugs, highlighting the statistically enriched fragments.
: Fragment 2 -The representative fragment for the second cluster is shown in the left panel, and drugs that contain a fragment in this cluster are shown in the right panel. The enriched fragment corresponds to chlormethine (minus the methyl group), the prototype drug of the nitrogen mustard alkylating agents, the class to which all the other compounds shown here belong.
Enrichment analysis
The analyze program was used to perform enrichment analysis on the antineoplastic set, clustering the fragments at a Tanimoto similarity of 0.8. Four clusters of fragments found to be significantly enriched (FDR <= 0.001) and together occurring > 5 times in the main set are highlighted in Figure 2 in the main text and Figures 1-3 here. We note that the analyze program found 2 additional enriched clusters that correspond to full molecules (i.e., they could not be fragmented according to the rules used), and 1 additional enriched cluster whose fragments overlapped those of one of the four main clusters (due to extensive fragementation). For convenience, these are not shown here. from each other at the global level, all share a heterocyclic aromatic nitrogen compound with a double-ring structure (quinoline). Quinoline has recently been called a "privileged" sca↵old in cancer drug discovery [4] .
